The acquisition creates the ninth-largest U.S. bank and signals accelerating consolidation within the regional banking sector.
FDA grants Breakthrough Therapy status for a promising new drug targeting the rare and fatal Sanfilippo Syndrome Type B.
The biotech firm secured its sixth approval for the ZORYVE franchise, expanding its dermatology treatment to children as young as two.
The all-stock deal marks a significant move in the ongoing consolidation wave among U.S. regional banks, creating a new top-ten lender.
Despite a revenue beat, the semiconductor equipment supplier's net loss and missed earnings per share estimates sent shares tumbling in after-hours trading.
All-stock transaction marks significant consolidation in the regional banking sector, creating the 9th largest U.S. bank by assets.
The executive search firm's shares jumped over 19% after agreeing to an all-cash acquisition by an investor group led by Advent International and Corvex.
The all-cash deal, valued at $210 per share, paves the way for the creation of a diversified energy and industrial technology leader.